Here are four things to know:
1. Mr. Turner will be based in Sydney, Australia.
2. He has worked for DePuy Synthes, Zimmer Biomet, Smith & Nephew and other companies over his two decade-long career.
3. Mr. Turner specializes in sales and marketing functions.
4. OrthAlign reported 65,000 knee and 45,000 hip arthroplasties were completed in Australia and New Zealand in 2016 and the company hopes to capitalize on the growing markets.
More articles on devices:
Global bone growth stimulators market — Spinal fusion segment led in 2016
Mayfield Brain & Spine implants 1st Senza SCS system in region — 5 highlights
Xtant Medical reports $22.1M in revenue for Q1 2017 — 10 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
